Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies. METHODS: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B12 and B6. RESULTS: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled. CONCLUSIONS: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adjudication for Alzheimer’s phenotypes was done by a committee41, comprising at least two neurologists and a neuropsychologist.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [41]
In the citing paper
“Dementia diagnoses were made according to DSM‐IV criteria, based on longitudinal cognitive assessments, caregiver interviews, medical records, neuroimaging, and autopsy data when available.”
From Blood PCSK9 Impacts Alzheimer's Disease Risk in an APOE Genotype‐Dependent Manner: A Prospective Cohort Study (2026) · cites this paper as [18]
In the citing paper
“Overall, of the 19 selected cohort studies linking Hcy to the various cognitive outcomes, 12(63.2%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest [206,215,217,219,222-224,228,231,233-235]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [206]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Research works printed but not linked: 3
- Berg L, 1988, Psychopharmacol Bull, 24, 637
- Levin ML, 1953, Acta Unio Int Contr Cancrum, 9, 531
- 1996, Fed Regist, 61, 8781
Cited by
Items 701–800 of 1,022
S-Adenosylhomocysteine—a better indicator of vascular disease than homocysteine?
Wagner, C., & Koury, M. J. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1581 · Cited by 83
Niu, L., Yang, Q., Zheng, H.-R., Chen, Y., Wu, L., Tung, C., & Yang, Q. (2014) · RSC Advances · doi:10.1039/c4ra13526a · Cited by 74
Folate Biofortification of Potato by Tuber-Specific Expression of Four Folate Biosynthesis Genes
Lepeleire, J. D., Strobbe, S., Verstraete, J., Blancquaert, D., Ambach, L., Visser, R. G. F., Stove, C. P., & Straeten, D. V. D. (2017) · Molecular Plant · doi:10.1016/j.molp.2017.12.008 · Cited by 84
Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives
Lista, S., González‐Domínguez, R., López‐Ortiz, S., González‐Domínguez, Á., Menéndez, H., Martín-Hernández, J., Lucía, A., Emanuele, E., Centonze, D., Imbimbo, B. P., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101987 · Cited by 83
Ratiometric fluorescent nanosensors for selective detecting cysteine with upconversion luminescence
Guan, Y., Qu, S., Li, B., Zhang, L., Ma, H., & Zhang, L. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.09.034 · Cited by 77
Genetics of Vascular Dementia: Systematic Review and Meta-Analysis
Sun, J.-H., Tan, L., Wang, H.-F., Tan, M.-S., Tan, L., Li, J.-Q., Xu, W., Zhu, X.-C., Jiang, T., & Yu, J.-T. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143102 · Cited by 74
“MTHFR is the enzyme that regulates the levels of homocysteine, which has been confirmed to be a strong risk factor for vascular diseases [88] and dementia, especially AD [89].”
Betaine Transport in Kidney and Liver: Use of Betaine in Liver Injury
Kempson, S. A., Vovor-Dassu, K., & Day, C. R. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000356622 · Cited by 80
Wu, H., HUANG, C., Cheng, T., & Tseng, W. (2008) · Talanta · doi:10.1016/j.talanta.2008.03.004 · Cited by 74
Antony, A. C., Tang, Y.-S., Khan, R. A., Biju, M. P., Xiao, X., Li, Q.-J., Sun, X.-L., Jayaram, H. N., & Stabler, S. P. (2004) · Journal of Clinical Investigation · doi:10.1172/jci11548 · Cited by 74
“(c) Because chronic hyper-homocysteinemia is a major risk factor in a variety of occlusive vascular diseases (58–65), some neural tube defects (66–68), congenital heart defects (69), and, as demonstrated more recently, dementia and Alzheimer disease (70), the direct effects of homocysteine on RNA-protein and possibly…”
BackgroundSofi, F., Vecchio, S. L., Giuliani, G., Marcucci, R., Gori, A. M., Fedi, S., Casini, A., Surrenti, C., Abbate, R., & Gensini, G. F. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602112 · Cited by 73
“It has been known for years that increased levels of the amino acid Hcy are associated with an increased risk of CVD (Hankey & Eikelboom, 1999) and with the development of dementia and Alzheimer’s disease (Seshadri et al, 2002).”
BackgroundNiu, L., Zheng, H.-R., Chen, Y., Wu, L., Tung, C., & Yang, Q. (2014) · The Analyst · doi:10.1039/c3an01849k · Cited by 74
Plasma folate concentration and cognitive performance: Rotterdam Scan Study
de Lau, L. M. L., Refsum, H., Smith, A. D., Johnston, C., & Breteler, M. M. B. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.728 · Cited by 87
A colorimetric and fluorescent probe for detecting intracellular biothiols
Chen, C., Liu, W., Xu, C., & Liu, W. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.04.098 · Cited by 74
Hughes, C., Ward, M., Tracey, F., Hoey, L., Molloy, A. M., Pentieva, K. D., & McNulty, H. (2017) · Nutrients · doi:10.3390/nu9010053 · Cited by 84
Blumberg, J., Bailey, R., Sesso, H., & Ulrich, C. (2018) · Nutrients · doi:10.3390/nu10020248 · Cited by 74
Homocysteine and B vitamins in mild cognitive impairment and dementia
Quadri, P., Fragiacomo, C., Pezzati, R., Zanda, E., Tettamanti, M., & Lucca, U. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.191 · Cited by 73
Wang, H., Lu, Q., Li, M., Li, H., Liu, Y., Li, H., Zhang, Y., & Yao, S. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.03.063 · Cited by 74
IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders
Fillit, H., Hess, G., Hill, J., Bonnet, P., & Toso, C. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ae7aaf · Cited by 73
Mei, J., Tong, J., Wang, J., Qin, A., Sun, J. Z., & Tang, B. Z. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm32892e · Cited by 75
Zhang, X., Li, C., Cheng, X., Wang, X., & Zhang, B. (2007) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2007.07.094 · Cited by 73
Rincón, F., & Wright, C. B. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835c4f04 · Cited by 92
“However, prospective data from the Rotterdam study did not confirm a relationship between plasma homocysteine and cognitive impairment or decline, while data from Framingham found a robust association with incident dementia as well as Alzheimer disease [90].”
ResultAlzheimer’s disease causation by copper toxicity and treatment with zinc
Brewer, G. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00092 · Cited by 73
“Elevated homocysteine levels are a risk factor for AD (as they are for atherosclerosis) (Seshadri et al., 2002).”
BackgroundVitamin D, Homocysteine, and Folate in Subcortical Vascular Dementia and Alzheimer Dementia
Moretti, R., Caruso, P., Ben, M. D., Conti, C., Gazzin, S., & Tiribelli, C. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00169 · Cited by 84
“Moreover, homocysteine metabolism is regulated by the redox potential in the cell (Blom and Smulders, 2011; Pushpakumar et al., 2014; Zhou et al., 2014), by disruption of the trans-sulfuration pathway (Seshadri et al., 2002; Obeid and Herrmann, 2006; Blom and Smulders, 2011).”
BackgroundFolic Acid Supplementation in Dementia: A Preliminary Report
Sommer, B. R., Hoff, A. L., & Costa, M. (2003) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988703256052 · Cited by 73
Anees, P., Joseph, J. A., Sreejith, S., Menon, N. V., Kang, Y., Yu, S. W.-K., Ajayaghosh, A., & Zhao, Y. (2016) · Chemical Science · doi:10.1039/c5sc04986e · Cited by 72
Fu, Z., Yan, L., Zhang, X., Zhu, F.-F., Han, X., Fang, J., Wang, Y., & Peng, Y. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob00525c · Cited by 73
Duong, P., Tenkorang, M. A. A., Trieu, J., McCuiston, C., Rybalchenko, N., & Cunningham, R. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-0283-1 · Cited by 92
Why Is Homocysteine Toxic for the Nervous and Immune Systems?
Болдырев, А. А., Bryushkova, E. A., Mashkina, A. P., & Vladychenskaya, E. A. (2013) · Current Aging Science · doi:10.2174/18746098112059990007 · Cited by 76
Cheng, D., Kong, H., Pang, W., Yang, H., Lu, H., Huang, C., & Jiang, Y. (2016) · Nutritional Neuroscience · doi:10.1179/1476830514y.0000000136 · Cited by 86
Iacobazzi, V., Infantino, V., Castegna, A., & Andria, G. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.07.016 · Cited by 78
“Circulating homocysteine is present in different forms: 80–90% as protein-bound, 10–20% as homocysteine-cysteine mixed disulfide and homocystine (dimer of homocysteine) and less than 1% as free reduced form [6].”
BackgroundGenetic Encoding of Caged Cysteine and Caged Homocysteine in Bacterial and Mammalian Cells
Uprety, R., Luo, J., Liu, J., Naro, Y., Samanta, S., & Deiters, A. (2014) · ChemBioChem · doi:10.1002/cbic.201400073 · Cited by 74
Boyina, H. K., Kumar, B., & Diwan, P. V. (2016) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1231695 · Cited by 80
“Elevated total plasma Hcy more than 14 l M is termed as HHcy (Seshadri et al. 2002).”
BackgroundNi, J., Zhang, L., Zhou, T., Xu, W., Xue, J., Neng, C., & Wang, X. (2017) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2016.07.005 · Cited by 72
Cavallaro, R. A., Fuso, A., Nicolia, V., & Scarpa, S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091666 · Cited by 80
“in LOAD [1–8].”
Zhao, N., Gong, Q., Zhang, R., Yang, J., Huang, Z. Y., Li, N., & Tang, B. Z. (2015) · Journal of Materials Chemistry C · doi:10.1039/c5tc01159k · Cited by 72
Chan, A., & Shea, T. B. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04589.x · Cited by 71
“Folate deficiency fosters a decline in S-adenosyl methionine (SAM; the major methyl donor), decreasing DNA methylation during aging and AD (Morrison 1996; Seshadri et al. 2002) and increasing DNA breakage (Kruman et al. 2000, 2002).”
BackgroundA focus on homocysteine in autism.
Kałużna‐Czaplińska, J., Żurawicz, E., Michalska, M., & Rynkowski, J. M. (2013) · Acta Biochimica Polonica · doi:10.18388/abp.2013_1963 · Cited by 75
“, 2001) and neural tube defects (Nelen, 2001; Hague, 2003), mental illness, and cognitive impairment (Seshadri et al., 2002; Nilsson et al., 2002).”
BackgroundLifestyle and health‐related risk factors and risk of cognitive aging among older veterans
Yaffe, K. S., Hoang, T. D. M., Byers, A. L., Barnes, D. E., & Friedl, K. E. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.010 · Cited by 90
Reversible Fluorescent Probe for Highly Selective and Sensitive Detection of Mercapto Biomolecules
Wu, J., Sheng, R., Liu, W., Wang, P., Ma, J., Zhang, H., & Zhuang, X. (2011) · Inorganic Chemistry · doi:10.1021/ic200181p · Cited by 71
Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?
Ashrafian, H., Harling, L., Darzi, A. W., & Athanasiou, T. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9412-4 · Cited by 77
Algaidi, S. A., Christie, L. A., Jenkinson, A. M., Whalley, L. J., Riedel, G., & Platt, B. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.07.003 · Cited by 76
Gunstad, J., Bausserman, L., Paul, R. H., Tate, D. F., Hoth, K. F., Poppas, A., Jefferson, A. L., & Cohen, R. A. (2006) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2005.08.010 · Cited by 76
Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris water maze task
STRECK, E. L., Bavaresco, C. S., Netto, C. A., & Wyse, Â. T. D. S. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.12.013 · Cited by 71
Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease
O’Suilleabhain, P. E., Bottiglieri, T., Dewey, R. B., Sharma, S., & Diaz-Arrastia, R. R. (2004) · Movement Disorders · doi:10.1002/mds.20253 · Cited by 73
“5) B12 297 (83) B12 303 (149) Folate 21 (12) Folate 21 (13) Off vs.”
Clarke, R., Lewington, S., Sherliker, P., & Armitage, J. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328011aa71 · Cited by 71
Shi, J., Wang, Y., Tang, X., Liu, W., Jiang, H., Dou, W., & Liu, W. (2013) · Dyes and Pigments · doi:10.1016/j.dyepig.2013.09.021 · Cited by 70
Ilyas, A., Wijayasinghe, Y. S., Khan, I., Samaloty, N. M. E., Adnan, M., Dar, T. A., Poddar, N. K., Singh, L. R., Sharma, H., & Khan, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.964624 · Cited by 76
“Hyperhomocysteinemia is a risk factor for dementia and Alzheimer’s disease (Seshadri et al., 2002).”
BackgroundBovine serum albumin‐confined silver nanoclusters as fluorometric probe for detection of biothiols
Chen, Z., Lu, D., Cai, Z., Dong, C., & Shuang, S. (2014) · Luminescence · doi:10.1002/bio.2613 · Cited by 70
Hasegawa, T., Ukai, W., Jo, D.-G., Xu, X., Mattson, M. P., Nakagawa, M., Araki, W., Saito, T., & Yamada, T. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20514 · Cited by 70
“Individuals with elevated plasma concentrations of homocysteine are at increased risk of AD (Seshadri et al., 2002).”
BackgroundResultInfluentialDementia: Alzheimer pathology and vascular factors: From mutually exclusive to interaction
van Norden, A. G. W., van Dijk, E. J., de Laat, K. F., Scheltens, P., Olde-Rikkert, M. G. M., & de Leeuw, F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.003 · Cited by 89
A Bodipy-based derivative for selective fluorescence sensing of homocysteine and cysteine
Yue, Y., Guo, Y., Xu, J., & Shao, S. (2010) · New Journal of Chemistry · doi:10.1039/c0nj00720j · Cited by 70
Properties of an unusual heme cofactor in PLP-dependent cystathionine β-synthase
Singh, S., Madzelan, P., & Banerjee, R. (2007) · Nat. Prod. Rep. · doi:10.1039/b604182p · Cited by 70
Role of Gasotransmitters in Oxidative Stresses, Neuroinflammation, and Neuronal Repair
Shefa, U., Yeo, S. G., Kim, M., Song, I. O., Jung, J., Jeong, N. Y., & Huh, Y. (2017) · BioMed Research International · doi:10.1155/2017/1689341 · Cited by 78
“As H2S is predominantly produced endogenously in brain from cysteine by CBS, lower levels of H2S in the brain of the AD patients are a prominent risk factor for advancement of AD [149, 150].”
Stroke, Cognitive Decline and Vascular Dementia: The Silent Epidemic of the 21st Century
Román, G. C. (2003) · Neuroepidemiology · doi:10.1159/000069885 · Cited by 78
Kim, H., Kim, G., Jang, W., Kim, S. Y., & Chang, N. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-118 · Cited by 69
“Several cross-sectional [6-9] and longitudinal studies [10-13] have proposed that elevated Hcy levels may be an independent risk factor for impaired cognitive function or Alzheimer’s disease (AD).”
Cheng, T., Huang, W., Gao, D., Yang, Z., Zhang, C., Zhang, H., Zhang, J., Li, H., & Yang, X. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02814 · Cited by 72
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Al-Kuraishy, H. M., Al-Gareeb, A. I., Elewa, Y. H. A., Zahran, M. H., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01350-8 · Cited by 75
Therapeutic benefits of H2S in Alzheimer’s disease
Wei, H., Li, X., & Tang, X. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.01.006 · Cited by 72
“It is now established that elevated plasma Hcy is a strong, independent risk factor of AD [13,14,42–44].”
BackgroundMansoori, N., Tripathi, M., Luthra, K., Alam, R., Ramakrishnan, L., Sharma, S., Subramanian, A., Parveen, S., & Mukhopadhyay, A. K. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.018 · Cited by 79
“Eikelboom, 1999) and AD (Quadri et al., 2004; Seshadri et al., 2002).”
Plasma homocysteine, folate and B12 in chronic schizophrenia
Haidemenos, A., Kontis, D., Gazi, A., Kallai, E., Allin, M. P. G., & Boniatsi, L. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.05.011 · Cited by 68
“By impairing neuronal plasticity and promoting neuronal degeneration, homocysteine could contribute to the pathogenesis of neurodegenerative and psychiatric disorders (Mattson and Shea, 2003; Seshadri et al., 2002).”
BackgroundMa, Y., Liu, S., Yang, H., Wu, Y., Sun, H., Wang, J., Zhao, Q., Li, F., & Huang, W. (2012) · Journal of Materials Chemistry B · doi:10.1039/c2tb00259k · Cited by 69
Smith, D. E. C., Kok, R. M., Teerlink, T., Jakobs, C., & Smulders, Y. M. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.085 · Cited by 69
“Disorders of folate metabolism have been implicated in the pathogenesis of a wide variety of diseases, including neural tube defects (1), anemia (2), cardiovascular disease (3), cognitive dysfunction (4), and cancer (5).”
BackgroundMcCaddon, A., & Miller, J. W. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv022 · Cited by 69
One-carbon metabolism and Alzheimer's disease: is it all a methylation matter?
Fuso, A., & Scarpa, S. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.01.012 · Cited by 78
“Despite this recent acknowledgement, alterations of HCY levels and related compounds were only recently widely recognized as risk factors for LOAD and other forms of dementia (Clarke et al., 1998; Joosten et al., 1997; McCaddon et al., 1998; Seshadri et al., 2002).”
BackgroundDayon, L., Guiraud, S. P., Corthésy, J., Silva, L. D., Migliavacca, E., Tautvydaitė, D., Oikonomidi, A., Moullet, B., Henry, H., Métairon, S., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0270-x · Cited by 72
Turi, G. (2003) · Florence Research (University of Florence) · Cited by 69
Carman, A. J., Dacks, P. A., Lane, R. F., Shineman, D. W., & Fillit, H. M. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0021-7 · Cited by 85
Barve, A., Lowry, M., Escobedo, J. O., Huynh, K. T., Hakuna, L., & Strongin, R. M. (2014) · Chemical Communications · doi:10.1039/c4cc03527e · Cited by 67
Kim (2009) · Oncology Reports · doi:10.3892/or_00000373 · Cited by 73
Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma
Roedl, J. B., Bleich, S., Reulbach, U., Ręjdak, R., Naumann, G. O. H., Kruse, F. E., Schlötzer-Schrehardt, U. M., Kornhuber, J., & Jünemann, A. G. M. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-006-0598-z · Cited by 68
An ‘OFF–ON’ fluorescent probe for specially recognize on Cys and its application in bioimaging
Yang, Y.-T., Huo, F., Yin, C., Chao, J., & Zhang, Y. (2014) · Dyes and Pigments · doi:10.1016/j.dyepig.2014.11.004 · Cited by 68
Functional NMDA receptors in rat erythrocytes
Makhro, A., Wang, J., Vogel, J., Болдырев, А. А., Gassmann, M., Kaestner, L., & Bogdanova, A. Y. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00407.2009 · Cited by 69
Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohnʼs Disease
Ward, M. G., Kariyawasam, V. C., Mogan, S. B., Patel, K., Pantelidou, M., Sobczyńska‐Malefora, A., Porté, F., Griffin, N., Anderson, S. H. C., Sanderson, J. D., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000559 · Cited by 73
“Furthermore, B12 deficiency leads to hyperhomocysteinemia, which is an independent risk factor for ischemic heart disease(5) and dementia.(6) Serum B12 binds to 2 proteins in blood, transcobalamin I (haptocorrin) and transcobalamin II.”
BackgroundJakubowski, H. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.224 · Cited by 68
“Plasma Hcy is also a risk factor for dementia and Alzheimer’s disease (6).”
BackgroundPharmacology of epigenetics in brain disorders
Narayan, P., & Dragunow, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00526.x · Cited by 67
“Elevated levels of homocysteine have been observed in AD patients, and are associated with folate and vitamin B12 deficiency (Seshadri et al., 2002; Morris, 2003).”
BackgroundLi, S.-J., Fu, Y., Li, C., Li, Y., Yi, L., & Ouyang, J. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.09.031 · Cited by 67
Wolters, M., Str�hle, A., & Hahn, A. (2004) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-004-0169-6 · Cited by 80
B Vitamin Deficiency Promotes Tau Phosphorylation Through Regulation of GSK3β and PP2A
Nicolia, V., Fuso, A., Cavallaro, R. A., Di Luzio, A., & Scarpa, S. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1284 · Cited by 66
“SAM is synthesized in one-carbon metabolism (also known as homocysteine (HCY) metabolic cycle) and recent data demonstrated significant correlation between elevated plasma HCY and AD [28–34].”
Richard, E., Kuiper, R., Dijkgraaf, M. G. W., Van Gool, W. A., & for the Evaluation of Vascular care in Alzheimer's disease Study Group (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02217.x · Cited by 67
Homocysteine effects on brain volumes mapped in 732 elderly individuals
Rajagopalan, P., Hua, X., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2011) · NeuroReport · doi:10.1097/wnr.0b013e328346bf85 · Cited by 66
“People with high levels of the amino acid, homocysteine, in the blood have an increased risk for stroke, Alzheimer’s disease (AD), and age-related memory impairment [1].”
Naismith, S. L., Glozier, N., Burke, D., Carter, P. E., Scott, E. M., & Hickie, I. B. (2009) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2008.00102.x · Cited by 72
Biochemical Markers and Risk Factors of Alzheimers Disease
Flirski, M., & Sobów, T. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772704 · Cited by 74
“Recently, the results of a comprehensive, Framingham community-based, prospective trial have been published [131].”
BackgroundInfluentialHomocysteine as a Risk Factor for Cognitive Impairment in Stroke Patients
Sachdev, P. S., Valenzuela, M., Brodaty, H., Wang, X. L., Looi, J. C., Lorentz, L., Howard, L., Jones, M., Zagami, A. S., Gillies, D., et al. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000068481 · Cited by 74
Cui, K., Chen, Z., Wang, Z., Zhang, G., & Zhang, D. (2010) · The Analyst · doi:10.1039/c0an00456a · Cited by 67
G-quadruplex-based ultrasensitive and selective detection of histidine and cysteine
Li, H., Liu, J., Fang, Y., Qin, Y., Xu, S., Liu, Y., & Wang, E. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.09.024 · Cited by 67
“Abnormal levels of cysteine are related to many diseases, such as slowed growth, liver damage, skin lesions, Alzheimer’s disease and cardiovascular disease (Lin et al., 2011; Seshadri et al., 2002; Shahrokhian, 2001).”
BackgroundThe consequences of mitochondrial amyloid β-peptide in Alzheimer's disease
Muirhead, K. E. A., Borger, E., Aitken, L., Conway, S. J., & Gunn, F. J. (2010) · Biochemical Journal · doi:10.1042/bj20091941 · Cited by 83
Miao, P., Liu, L., Nie, Y., & Li, G. (2009) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2009.04.041 · Cited by 67
Green, R. (2008) · Food and Nutrition Bulletin · doi:10.1177/15648265080292s108 · Cited by 80
“Examples include osteopenia [49–51] and Alzheimer’s disease [52, 53].”
BackgroundFluorescent Sensor Based on BINOL for Recognition of Cysteine, Homocysteine, and Glutathione
Peng, R., Lin, L., Wu, X., Liu, X., & Feng, X. (2013) · The Journal of Organic Chemistry · doi:10.1021/jo401932n · Cited by 67
A Pilot Study of Vitamins to Lower Plasma Homocysteine Levels in Alzheimer Disease
Aisen, P. S. S., Egelko, S., Andrews, H., Diaz-Arrastia, R. R., Weiner, M., DeCarli, C. S., Jagust, W., Miller, J. W., Green, R., Bell, K. L., et al. (2003) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200303000-00016 · Cited by 67
“(F[2,66] 5.”
MethodScott, T. M., Peter, I., Tucker, K. L., Arsenault, L., Bergethon, P., Bhadelia, R., Buell, J., Collins, L., Dashe, J. F., Griffith, J., et al. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1503 · Cited by 65
Self-citationThe undertow of sulfur metabolism on glutamatergic neurotransmission
Banerjee, R. V., Vitvitsky, V., & Garg, S. K. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.06.006 · Cited by 67
Does Helicobacter pylori Infection Increase Incidence of Dementia? The Personnes Agées QUID Study
Roubaud Baudron, C., Letenneur, L., Langlais, A., Buissonnière, A., Mégraud, F., Dartigues, J., Salles, N., & Study, F. T. P. A. Q. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12065 · Cited by 66
“pylori infection may play a role in neuron damage leading to dementia is a higher plasma homocysteine level, leading to endothelial damage, cerebrovascular lesions, and ultimately neurodegeneration.(28) Chronic atrophic gastritis due to H.”
BackgroundZwilling, C. E., Talukdar, T., Zamroziewicz, M. K., & Barbey, A. K. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.12.007 · Cited by 78
“However, despite an abundance of evidence in favor of a single or a few nutrients for the promotion of cognitive health (Morris et al., 2002, 2005; Rinaldi et al., 2003; Seshadri et al., 2002; Scarmeas et al., 2006; Barberger-Gateau et al., 2007; Schaefer et al., 2006) and brain aging (Zamroziewicz and Barbey, 2016; Z…”
Gold alloy-based nanozyme sensor arrays for biothiol detection
Lin, J., Wang, Q., Wang, X., Zhu, Y., Zhou, X., & Wei, H. (2020) · The Analyst · doi:10.1039/d0an00451k · Cited by 68
McCracken, C., Hudson, P. R., Ellis, R., & McCaddon, A. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.6.1406 · Cited by 76
Zhou, F., & Chen, S. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.02.006 · Cited by 67
Formaldehyde and Brain Disorders: A Meta-Analysis and Bioinformatics Approach
Rana, I., Rieswijk, L., Steinmaus, C., & Zhang, L. (2021) · Neurotoxicity Research · doi:10.1007/s12640-020-00320-y · Cited by 71
Madsen, S. K., Rajagopalan, P., Joshi, S. H., Toga, A. W., & Thompson, P. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.154 · Cited by 68
“The neurotoxic effects could explain the association between elevated homocysteine levels and dementia risk (Seshadri et al., 2002), white matter (WM) deterioration (Rajagopalan et al., 2011), and, as evaluated in the present study, altered pro fi les of cortical gray matter (GM) thickness and…”
InfluentialImportance of the trans-sulfuration pathway in cancer prevention and promotion
Rosado, J. O., Salvador, M. M., & Bonatto, D. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9389-y · Cited by 72
“[44], as well as neurodegenerative diseases like Alzheimers and dementia [45].”
Background
Metadata
- Authors
- Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A.
- Affiliations
- Boston University (US)
- Tufts University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-02-14
- Volume
- 346
- Issue
- 7
- Pages
- 476-483
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2052588755
- Cited by
- 3,237
- References
- 55
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 82 · 2023: 79 · 2022: 90 · 2021: 102 · 2020: 91 · 2019: 133 · 2018: 132 · 2017: 138 · 2016: 138 · 2015: 149 · 2014: 174 · 2013: 154 · 2012: 155
- FWCI
- 111.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc038038-022)
- National Institute on Aging (5R01 AG 08122-11, 5R01-AG16495-02, R01AG016495, R01AG008122)
- National Heart, Lung, and Blood Institute (N01-HC-38038)
- National Institute of Neurological Disorders and Stroke (5R01 NS 17950-19, R01NS017950)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- plasma homocysteine, dementia, Alzheimer's disease, risk factors, newly diagnosed dementia, folic acid, vitamin B12, vitamin B6, apolipoprotein E, Framingham Heart Study, cognitive decline
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Dementia, Female, Homocysteine, Humans, Male, Risk Factors, Cohort Studies, Confounding Factors, Epidemiologic, Multivariate Analysis, Proportional Hazards Models, Hyperhomocysteinemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.